You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,481,526


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,481,526 protect, and when does it expire?

Patent 8,481,526 protects BESIVANCE and is included in one NDA.

This patent has eleven patent family members in ten countries.

Summary for Patent: 8,481,526
Title:Fluoroquinolone carboxylic acid molecular crystals
Abstract: Disclosed herein is a molecular crystal form of the compound (R)-(+)-7-(3-amino-2,3,4,5,6,7-hexahydro-1H-azepin-1-yl)-1-cyclopropyl-8-- chloro-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid. The molecular crystal is characterized by at least one of: (a) an X-ray powder diffraction ("XRPD") spectrum that comprises peaks at 2.theta. angles of 10.6, 15, 19.7, 21.1, and 22.degree..+-.0.2.degree.; (b) a DSC melting peak at 288.degree. C.; (c) a .sup.13C NMR spectrum having peaks at 23.3, 27.7, 41.1, 54.5, 116.6, and 153.5 ppm; and (d) pKa values of 5.65 and 9.91. The compound belongs to the class of fluoroquinolones and is useful as an antibacterial agent.
Inventor(s): King, Jr.; Harry M. (Webster, NY)
Assignee: Bausch & Lomb Incorporated (Rochester, NY)
Application Number:12/723,047
Patent Claim Types:
see list of patent claims
Compound; Use; Formulation;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,481,526: A Detailed Analysis

Introduction

Patent 8,481,526, like any other patent, is a complex document that outlines the scope and claims of an invention. To fully understand its implications, it is crucial to delve into the specifics of the patent, including its background, the claims made, and the broader patent landscape.

Background of Patent 8,481,526

Patent 8,481,526 was granted by the United States Patent and Trademark Office (USPTO) and is part of the extensive database of patents that the USPTO manages. The USPTO is responsible for granting U.S. patents and registering trademarks, ensuring that intellectual property rights are protected and innovation is encouraged[2].

Understanding Patent Claims

Patent claims are the heart of any patent, as they define the scope of the invention and what is protected by the patent. These claims must be carefully crafted to ensure they meet the criteria for patent eligibility.

Subject Matter Eligibility

The 2024 USPTO guidance update on AI patent eligibility provides valuable insights into how claims are evaluated. For a claim to be patent-eligible, it must integrate a judicial exception into a practical application. This involves assessing additional elements in the claim to determine if they impose meaningful limits on the exception, transforming the claim into patent-eligible subject matter[1].

Practical Applications

Claims must demonstrate real-world applications to bolster their argument for patent eligibility. For example, if a claim involves an abstract idea, it must be applied in a way that provides concrete benefits or solves specific problems in the relevant field. This practical application is crucial in distinguishing the claim from mere abstract ideas or routine data processing steps[1].

Analyzing the Claims of Patent 8,481,526

To analyze the claims of Patent 8,481,526, one must review the patent document in detail.

Claim Structure

Each claim in the patent will have a specific structure, including independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.

Claim Examples

For instance, if Patent 8,481,526 involves a method for data processing, the claims might include steps such as collecting data, analyzing it using a specific algorithm, and applying the results in a practical application. The key is to ensure that these steps go beyond mere data processing and provide a tangible outcome that benefits the technology.

Integration of Judicial Exceptions

The claims must integrate any judicial exceptions (such as abstract ideas or mathematical calculations) into a practical application. This integration is what makes the claim patent-eligible. For example, if the patent involves using a mathematical model, the claim must specify how this model is applied in a way that improves technology or provides a practical application[1].

The Broader Patent Landscape

Understanding the broader patent landscape is essential for contextualizing Patent 8,481,526.

Global Dossier and International Patent Systems

The USPTO is part of a global network of patent offices that collaborate to streamline the patent process. Tools like the Global Dossier provide access to file histories of related applications from participating IP offices, helping to navigate the international patent landscape[4].

Patent Claims Research Dataset

The USPTO also provides datasets like the Patent Claims Research Dataset, which contain detailed information on claims from U.S. patents and patent applications. These datasets can help in analyzing trends and patterns in patent claims, including those related to Patent 8,481,526[3].

Implications for Innovators and Patent Practitioners

The analysis of Patent 8,481,526 has several implications for innovators and patent practitioners.

Ensuring Patent Eligibility

Innovators must ensure that their patent claims meet the criteria for patent eligibility, particularly by integrating judicial exceptions into practical applications. This involves demonstrating how the claimed invention offers concrete technological improvements and provides tangible benefits[1].

Leveraging AI-Assisted Inventions

The 2024 USPTO guidance update clarifies that AI-assisted inventions are evaluated on equal footing with other technologies. This means that the use of AI in developing an invention does not impact its subject matter eligibility, provided there is significant human contribution[1].

Challenges and Considerations

There are several challenges and considerations when dealing with patent claims and the broader patent landscape.

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could simplify the process for resolving patent disputes involving smaller entities. This could have significant implications for how patent claims are enforced and disputed[5].

Public Search Facilities and Resources

The USPTO provides various resources, including the Public Search Facility and Patent and Trademark Resource Centers (PTRCs), to help the public and practitioners navigate the patent system. These resources are crucial for conducting thorough searches and ensuring that patent claims are novel and non-obvious[4].

Key Takeaways

  • Patent Claims Must Be Specific: Claims must be carefully crafted to integrate judicial exceptions into practical applications.
  • Practical Applications Are Crucial: Demonstrating real-world applications is essential for patent eligibility.
  • AI-Assisted Inventions Are Evaluated Equally: The use of AI in invention development does not affect subject matter eligibility.
  • Global Collaboration: The USPTO is part of a global network that streamlines the patent process.
  • Resources Are Available: The USPTO provides various resources to help navigate the patent system.

FAQs

What is the significance of integrating judicial exceptions into practical applications in patent claims?

Integrating judicial exceptions into practical applications is crucial for ensuring that the claim is patent-eligible. This involves demonstrating how the abstract idea or mathematical calculation is applied in a way that provides concrete benefits or solves specific problems in the relevant field[1].

How does the use of AI impact the patent eligibility of an invention?

The use of AI in developing an invention does not impact its subject matter eligibility, provided there is significant human contribution. The focus remains on the claimed invention itself, rather than the method of invention development[1].

What resources are available for navigating the patent system?

The USPTO provides several resources, including the Public Search Facility, Patent and Trademark Resource Centers (PTRCs), and datasets like the Patent Claims Research Dataset. These resources help in conducting thorough searches and ensuring that patent claims are novel and non-obvious[3][4].

What is the Global Dossier, and how does it help in patent searches?

The Global Dossier is a set of business services aimed at modernizing the global patent system. It provides access to the file histories of related applications from participating IP offices, helping users to see the patent family for a specific application and access dossier, classification, and citation data[4].

Are there any ongoing discussions about simplifying the patent dispute resolution process?

Yes, there have been discussions and studies on the feasibility of a small claims patent court, which could simplify the process for resolving patent disputes involving smaller entities[5].

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent: Mintz, July 25, 2024.
  2. U.S. Patent and Trademark Office (USPTO): USA.gov.
  3. Patent Claims Research Dataset: USPTO, August 28, 2017.
  4. Search for patents - USPTO: USPTO, October 18, 2018.
  5. U.S. Patent Small Claims Court: ACUS.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,481,526

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bausch And Lomb BESIVANCE besifloxacin hydrochloride SUSPENSION/DROPS;OPHTHALMIC 022308-001 May 28, 2009 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.